116 related articles for article (PubMed ID: 33016303)
1. A simple self-adjuvanting biomimetic nanovaccine self-assembled with the conjugate of phospholipids and nucleotides can induce a strong cancer immunotherapeutic effect.
Liu D; Liu J; Ma B; Deng B; Leng X; Kong D; Liu L
Biomater Sci; 2021 Jan; 9(1):84-92. PubMed ID: 33016303
[TBL] [Abstract][Full Text] [Related]
2. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
[TBL] [Abstract][Full Text] [Related]
3. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy.
Song H; Su Q; Shi W; Huang P; Zhang C; Zhang C; Liu Q; Wang W
Acta Biomater; 2022 Mar; 141():398-407. PubMed ID: 35007785
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Antitumor Immune Responses via a Self-Assembled Carrier-Free Nanovaccine.
Liu D; Deng B; Liu Z; Ma B; Leng X; Kong D; Ji T; Liu L
Nano Lett; 2021 May; 21(9):3965-3973. PubMed ID: 33886338
[TBL] [Abstract][Full Text] [Related]
5. Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity.
Xu Y; Ma S; Zhao J; Chen H; Si X; Huang Z; Yu Z; Song W; Tang Z; Chen X
Biomaterials; 2022 May; 284():121489. PubMed ID: 35364489
[TBL] [Abstract][Full Text] [Related]
6. Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase.
Guan X; Chen J; Hu Y; Lin L; Sun P; Tian H; Chen X
Biomaterials; 2018 Jul; 171():198-206. PubMed ID: 29698869
[TBL] [Abstract][Full Text] [Related]
7. A biotin-avidin-system-based virus-mimicking nanovaccine for tumor immunotherapy.
Lu Z; Zhang Y; Wang Y; Tan GH; Huang FY; Cao R; He N; Zhang L
J Control Release; 2021 Apr; 332():245-259. PubMed ID: 33647430
[TBL] [Abstract][Full Text] [Related]
8. Leveraging β-Adrenergic Receptor Signaling Blockade for Improved Cancer Immunotherapy Through Biomimetic Nanovaccine.
Yang C; He Y; Chen F; Zhang F; Shao D; Wang Z
Small; 2023 Apr; 19(14):e2207029. PubMed ID: 36703529
[TBL] [Abstract][Full Text] [Related]
9. Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy.
Wang K; Zhang X; Ye H; Wang X; Fan Z; Lu Q; Li S; Zhao J; Zheng S; He Z; Ni Q; Chen X; Sun J
Nat Commun; 2023 Oct; 14(1):6748. PubMed ID: 37875481
[TBL] [Abstract][Full Text] [Related]
10. An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer.
Zhang Y; Jiang M; Du G; Zhong X; He C; Qin M; Hou Y; Liu R; Sun X
Acta Pharm Sin B; 2023 Aug; 13(8):3518-3534. PubMed ID: 37655327
[TBL] [Abstract][Full Text] [Related]
11. A General Strategy toward Self-assembled Nanovaccine Based on Cationic Lentinan to Induce Potent Humoral and Cellular Immune Responses.
Yu R; Jin L; Song Z; Jiao L; Wang Z; Zhou Y; Ma Y; Guan S; Zhang Z; Wang D; Liu H; Sun Y; Zhang S; Cai T; Sun H; Qiu Y; Miao J; Liu Z
Small; 2024 Jun; ():e2402792. PubMed ID: 38940386
[TBL] [Abstract][Full Text] [Related]
12. Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy.
Jiang M; Zhao L; Cui X; Wu X; Zhang Y; Guan X; Ma J; Zhang W
J Adv Res; 2022 Jan; 35():49-60. PubMed ID: 35003793
[TBL] [Abstract][Full Text] [Related]
13. Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy.
Qian Y; Jin H; Qiao S; Dai Y; Huang C; Lu L; Luo Q; Zhang Z
Biomaterials; 2016 Aug; 98():171-83. PubMed ID: 27192420
[TBL] [Abstract][Full Text] [Related]
14. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
[TBL] [Abstract][Full Text] [Related]
15. Necroptotic cancer cells-mimicry nanovaccine boosts anti-tumor immunity with tailored immune-stimulatory modality.
Kang T; Huang Y; Zhu Q; Cheng H; Pei Y; Feng J; Xu M; Jiang G; Song Q; Jiang T; Chen H; Gao X; Chen J
Biomaterials; 2018 May; 164():80-97. PubMed ID: 29499438
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of CpG-ODN-adjuvanted polyanhydride-based intranasal influenza nanovaccine in pigs.
Dhakal S; Ghimire S; Renu S; Ross KA; Lakshmanappa YS; Hogshead BT; Bernardo P; Lee CW; Wannemuehler MJ; Narasimhan B; Renukaradhya GJ
Vet Microbiol; 2019 Oct; 237():108401. PubMed ID: 31585639
[TBL] [Abstract][Full Text] [Related]
17. Personalized Nanovaccine Coated with Calcinetin-Expressed Cancer Cell Membrane Antigen for Cancer Immunotherapy.
Xiong X; Zhao J; Pan J; Liu C; Guo X; Zhou S
Nano Lett; 2021 Oct; 21(19):8418-8425. PubMed ID: 34546061
[TBL] [Abstract][Full Text] [Related]
18. A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response.
Liu X; Liu J; Liu D; Han Y; Xu H; Liu L; Leng X; Kong D
Biomater Sci; 2019 Dec; 7(12):5516-5527. PubMed ID: 31670734
[TBL] [Abstract][Full Text] [Related]
19. Splenic-targeting biomimetic nanovaccine for elevating protective immunity against virus infection.
Huo J; Zhang A; Wang S; Cheng H; Fan D; Huang R; Wang Y; Wan B; Zhang G; He H
J Nanobiotechnology; 2022 Dec; 20(1):514. PubMed ID: 36463277
[TBL] [Abstract][Full Text] [Related]
20. A STING-activating nanovaccine for cancer immunotherapy.
Luo M; Wang H; Wang Z; Cai H; Lu Z; Li Y; Du M; Huang G; Wang C; Chen X; Porembka MR; Lea J; Frankel AE; Fu YX; Chen ZJ; Gao J
Nat Nanotechnol; 2017 Jul; 12(7):648-654. PubMed ID: 28436963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]